315 related articles for article (PubMed ID: 11068549)
1. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
3. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J
Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476
[TBL] [Abstract][Full Text] [Related]
4. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
[TBL] [Abstract][Full Text] [Related]
5. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors.
Schürch W; Skalli O; Seemayer TA; Gabbiani G
Am J Pathol; 1987 Jul; 128(1):91-103. PubMed ID: 2440309
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical differentiation of leiomyocellular tumors and tumors with myogenic differentiation].
Povýsil C; Ciprová V; Dundr P; Horáková M
Cesk Patol; 2003 Apr; 39(2):64-8. PubMed ID: 12874903
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus].
Farah-Klibi F; Ben Hamouda S; Ben Romdhane S; Sfar R; Koubaa A; Ben Jilani S; Zermani R
J Gynecol Obstet Biol Reprod (Paris); 2008 Sep; 37(5):457-62. PubMed ID: 18565690
[TBL] [Abstract][Full Text] [Related]
8. Alpha-smooth muscle actin as a marker for soft tissue tumours: a comparison with desmin.
Jones H; Steart PV; Du Boulay CE; Roche WR
J Pathol; 1990 Sep; 162(1):29-33. PubMed ID: 2231189
[TBL] [Abstract][Full Text] [Related]
9. Expression of smooth muscle markers in so called malignant fibrous histiocytomas.
Hasegawa T; Hasegawa F; Hirose T; Sano T; Matsuno Y
J Clin Pathol; 2003 Sep; 56(9):666-71. PubMed ID: 12944549
[TBL] [Abstract][Full Text] [Related]
10. Antibody specific to muscle actins in the diagnosis and classification of soft tissue tumors.
Miettinen M
Am J Pathol; 1988 Jan; 130(1):205-15. PubMed ID: 3276210
[TBL] [Abstract][Full Text] [Related]
11. Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors.
Dundr P; Povýsil C; Tvrdík D
Pathol Int; 2009 Feb; 59(2):86-90. PubMed ID: 19154261
[TBL] [Abstract][Full Text] [Related]
12. Pseudosarcomatous myofibroblastic tumor and myosarcoma of the urogenital tract.
Watanabe K; Baba K; Saito A; Hoshi N; Suzuki T
Arch Pathol Lab Med; 2001 Aug; 125(8):1070-3. PubMed ID: 11473460
[TBL] [Abstract][Full Text] [Related]
13. h-Caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors.
Watanabe K; Tajino T; Sekiguchi M; Suzuki T
Am J Clin Pathol; 2000 May; 113(5):663-8. PubMed ID: 10800398
[TBL] [Abstract][Full Text] [Related]
14. Specific but variable expression of h-caldesmon in leiomyosarcomas: an immunohistochemical reassessment of a novel myogenic marker.
Hisaoka M; Wei-Qi S; Jian W; Morio T; Hashimoto H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):302-8. PubMed ID: 11759055
[TBL] [Abstract][Full Text] [Related]
15. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
17. [Myoepithelial differentiation markers in salivary gland neoplasia].
Scarpellini F; Marucci G; Foschini MP
Pathologica; 2001 Dec; 93(6):662-7. PubMed ID: 11785118
[TBL] [Abstract][Full Text] [Related]
18. The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. part 2 - tumours and tumour-like lesions.
Eyden B
J Submicrosc Cytol Pathol; 2005 Nov; 37(3-4):231-96. PubMed ID: 16612972
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases.
Nicolas MM; Tamboli P; Gomez JA; Czerniak BA
Hum Pathol; 2010 May; 41(5):663-71. PubMed ID: 20004935
[TBL] [Abstract][Full Text] [Related]
20. Undifferentiated (embryonal) sarcoma of the liver in middle-aged adults: smooth muscle differentiation determined by immunohistochemistry and electron microscopy.
Nishio J; Iwasaki H; Sakashita N; Haraoka S; Isayama T; Naito M; Miyayama H; Yamashita Y; Kikuchi M
Hum Pathol; 2003 Mar; 34(3):246-52. PubMed ID: 12673559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
